Suspension of trading

ICAD Stock

ICAD

US44934S2068

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 16:00:00 2025-07-16 EDT			5-day change	1st Jan Change
3.870 ^USD	+3.75%		-.--%	-

25-07-20	ICAD, Inc.(NasdaqCM:ICAD) dropped from S&P TMI Index	CI
25-07-17	ICAD, Inc.(NasdaqCM:ICAD) dropped from Russell Microcap Value Benchmark Index	CI

Analysts' recommendations: ICAD

25-04-17	RadNet's iCAD Deal to Expand its Digital Health Services and Geographic Presence, Truist Says	MT
25-04-17	BTIG Research Downgrades iCAD to Neutral From Buy	MT
23-07-19	Lake Street Adjusts Price Target on icad to $5 From $2.50, Maintains Buy Rating	MT
23-04-13	JMP Securities Adjusts iCAD's Price Target to $4 From $7, Keeps Outperform Rating	MT
23-04-04	Oppenheimer Adjusts iCAD Price Target to $4 From $5, Maintains Outperform Rating	MT

More recommendations

iCAD Inc is a United Statesâ€‘based company. The Company develops artificial intelligence solutions designed to support healthcare providers in the detection and diagnosis of cancer. The company focuses on providing clinically proven AI technologies that assist medical professionals in identifying cancer earlier, improving diagnostic accuracy, and enhancing workflow efficiency. Its solutions include platforms for cancer detection, breast density assessment, and risk evaluation, enabling clinicians to analyze medical images and support patient care decisions. The company leverages advanced data, clinical evidence, and AIâ€‘driven technologies to deliver tools that integrate into existing healthcare systems and assist in screening and diagnostic processes across global markets.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Stock Market
Stocks
ICAD Stock

As early as today, start finding the best investment opportunities!

Market Cap	106M 92.88M 87.56M 79.88M 149M 10.14B 151M 1.05B 407M 5.16B 396M 388M 16.79B	P/E 2023	-9.35x	P/E 2024	-8.59x
Enterprise Value	88.75M 78.06M 73.59M 67.14M 126M 8.52B 127M 883M 342M 4.34B 333M 326M 14.11B	EV / Sales 2023	1.47x	EV / Sales 2024	1.6x
Free-Float	99.32%	Yield 2023 *	-	Yield 2024	-

25-07-08	ICAD Announces Proxy Advisory Firms ISS and Glass Lewis Recommend Stockholders Vote “FOR” Proposed Acquisition by RadNet, Inc.	AQ
25-06-03	ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc. - ICAD	BU
25-05-13	ICAD Reports Financial Results for First Quarter Ended March 31, 2025	AQ
25-04-29	ICAD Collaborates with Microsoft to provide access to its Mammography Solutions in Microsoft’s Precision Imaging Network (PIN)	AQ
25-04-17	ICAD INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of iCAD, Inc. - ICAD	BU

23-03-13	LA PREMIÈRE ÉTAPE DE L’OPÉRATION CONSISTE EN LA CESSION PAR ICAD…
21-04-26	CAC 40 : Les valeurs à suivre à Paris et en Europe
21-04-26	Les valeurs à suivre à Paris et en Europe (actualisé)
19-10-18	ICAD : annonce l’installation de la solution ProFound AI™ 2D pour la mammographie et pour la tomosynthèse (DBT) 3D au Centre d’Imagerie Paris Nord Sarcelles
19-01-25	Dow Jones Industrial Average : Wall Street attendue en hausse malgré Intel et les doutes sur la croissance

3 years	1.18	4.02
5 years	1.05	12.6
10 years	1.05	21.44

Manager	Title	Age	Since
Dana Brown CEO	Chief Executive Officer	61	2023-03-09
Mark Stolper DFI	Director of Finance/CFO	54	2025-07-16
Dave Katz SEC	Corporate Secretary	-	2025-07-16

ICAD Stock

Stocks

ICAD

US44934S2068

Advanced Medical Equipment & Technology

Valuation: ICAD

Latest news: ICAD

Analysts' recommendations: ICAD

Press Releases: ICAD

News in other languages: ICAD

Quotes and Performance

Price Extremes

Managers and Directors: ICAD

Latest insider transactions

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Date	Insider	Type	Main position	Quantity	% Market Cap.
7/17/25	Andrew Sassine	Issuer sale	Director	1,553,657	5.8540%
7/17/25	Eric Lonnqvist	Issuer sale	Chief Financial Officer	158,488	0.5972%
7/17/25	Jonathan Go	Issuer sale	Chief Technology Officer	351,145	1.3231%

	2023	2024
Net sales	17.32M 15.23M 14.36M 13.1M 24.5M 1.66B 24.69M 172M 66.78M 846M 65.02M 63.61M 2.75B	19.61M 17.25M 16.26M 14.83M 27.74M 1.88B 27.96M 195M 75.61M 958M 73.62M 72.02M 3.12B
Net income	-4.85M -4.26M -4.02M -3.67M -6.86M -465M -6.91M -48.23M -18.69M -237M -18.2M -17.8M -771M	-5.62M -4.94M -4.66M -4.25M -7.95M -539M -8.01M -55.88M -21.65M -274M -21.09M -20.63M -893M
Net Debt	-21.21M -18.66M -17.59M -16.05M -30.01M -2.04B -30.24M -211M -81.78M -1.04B -79.63M -77.9M -3.37B	-16.84M -14.82M -13.97M -12.74M -23.83M -1.62B -24.02M -168M -64.95M -823M -63.24M -61.87M -2.68B

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
ICAD	+3.75%	-.--%	-.--%	+104.76%	106M
THERMO FISHER SCIENTIFIC, INC.	+1.97%	+4.62%	+44.42%	+34.93%	246B
DANAHER CORPORATION	+1.00%	+7.40%	+17.95%	-9.90%	156B
INTUITIVE SURGICAL, INC.	+0.31%	+4.51%	-10.77%	+38.63%	141B
BOSTON SCIENTIFIC CORPORATION	+0.13%	+1.75%	-54.26%	-16.64%	64.66B
EDWARDS LIFESCIENCES CORPORATION	-1.26%	-3.98%	+14.97%	+23.07%	50.04B
SIEMENS HEALTHINEERS AG	+0.03%	-3.00%	-20.96%	-21.61%	47.18B
AGILENT TECHNOLOGIES, INC.	+4.55%	+12.46%	+37.24%	+55.14%	46.61B
WATERS CORPORATION	+2.31%	+2.79%	+43.81%	+59.96%	41.32B
ILLUMINA, INC.	+7.25%	+19.64%	+175.64%	+106.81%	38.56B
Average	+2.00%	+3.21%	+24.80%	+37.51%	83.09B
Weighted average by Cap.	+1.47%	+3.64%	+22.60%	+24.94%